Palifermin reduces severe oral mucositis (OM), improves patient quality of life, and reduces health resource use in patients with hematologic malignancies receiving high-dose chemotherapy (HDCT) and total body irradiation (TBI) with autologous peripheral blood stem cell (PBSC) support: Results from a phase III trial Meeting Abstract
| Authors: | Bensinger, W.; Weisdorf, D.; Gentile, T.; Cesano, A.; Elhardt, D.; Emmanouilides, C.; Erder, M. H.; Hansen, K.; Isitt, J.; Kewalramani, T.; McCarty, J.; Noga, S.; Rong, A.; Shea, T.; Spielberger, R.; Yanovich, S.; Stiff, P. |
| Abstract Title: | Palifermin reduces severe oral mucositis (OM), improves patient quality of life, and reduces health resource use in patients with hematologic malignancies receiving high-dose chemotherapy (HDCT) and total body irradiation (TBI) with autologous peripheral blood stem cell (PBSC) support: Results from a phase III trial |
| Meeting Title: | 2004 Tandem BMT Meetings |
| Journal Title: | Biology of Blood and Marrow Transplantation |
| Volume: | 10 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2004 Feb 13-17 |
| Meeting Location: | Orlando, FL |
| ISSN: | 1083-8791 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2004-02-01 |
| Start Page: | 31 |
| Language: | English |
| ACCESSION: | WOS:000188877500068 |
| DOI: | 10.1016/j.bbmt.2003.12.135 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 66 -- Oral presentation -- Tandem BMT 2004 Meeting -- FEB 13-17, 2004 -- ORLANDO, FLORIDA -- 1 -- Source: Wos |
